Babu-Narayan, Sonya V, Uebing, Anselm, Davlouros, Periklis A, Kemp, Michael, Davidson, Simon, Dimopoulos, Konstantinos, Bayne, Stephanie, Pennell, Dudley J, Gibson, Derek G, Flather, Marcus, Kilner, Philip J, Li, Wei and Gatzoulis, Michael A (2012) Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation:the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot). International Journal of Cardiology, 154 (3). pp. 299-305. ISSN 1874-1754
Full text not available from this repository. (Request a copy)Abstract
Optimal treatment for stable repaired tetralogy of Fallot (rTOF) patients with pulmonary regurgitation (PR) and related right ventricular (RV) dilatation, including timing of valve implantation, remains uncertain. We sought to study tolerability of the angiotensin-converting-enzyme (ACE) inhibitor ramipril and its effects on cardiovascular function in these patients.
Item Type: | Article |
---|---|
Additional Information: | Copyright © 2010. Published by Elsevier Ireland Ltd. |
Uncontrolled Keywords: | angiotensin-converting enzyme inhibitors,double-blind method,feasibility studies,humans,prospective studies,pulmonary valve insufficiency,ramipril,tetralogy of fallot,time factors,ventricular function |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) |
Depositing User: | Pure Connector |
Date Deposited: | 20 Jan 2014 16:12 |
Last Modified: | 24 Oct 2022 05:35 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/46244 |
DOI: | 10.1016/j.ijcard.2010.09.057 |
Actions (login required)
View Item |